Company
Headquarters: Carson City, NV, United States
$34,958
USD as of July 1, 2022
| Company | Market Cap (USD) |
|---|---|
| GE HealthCare | $34.86 B |
| Veeva Systems Inc. | $29.97 B |
| M3, Inc. | $11.24 B |
| Change Healthcare Inc. | $9.03 B |
| Signify Health, Inc. | $8.38 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Cancer Treatment Holdings, Inc., through its subsidiaries, engages in providing IT-enabled services; the exploitation of an invention related to the on-site production of chlorine gas and related compounds; and providing radiation therapy, diagnostic imaging, and other medical related services. The company, through a 50% interest in a joint venture, offers IT-enabled services, including medical transcriptions, billing and collecting, bookkeeping, and claims processing services. The company enables users to manufacture chlorine on-site and when needed through its device. It has a 51% interest in a radiation therapy center located in Logan, West Virginia. In addition, through its wholly owned subsidiary, CTI Management Corp., the company's president provides management services. The company is based in Carson City, Nevada.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Cancer Treatment Holdings, Inc. has the following listings and related stock indices.
Stock: OTC: CTHZ wb_incandescent
Headquarters:
202 North Curry Street
Suite 100
Carson City, NV 89703
United States
Phone: 212-221-1340